Clinical Trials Browser

INDUSTRY × fedratinib × Other hematologic neoplasm × Clear all

NCT01420770 2025-03-05

Phase 2 Study of SAR302503 in Patients With Myelofibrosis

Phase 2 Completed

Other hematologic neoplasm

Hematologic Neoplasms

NCT01420783 2025-03-05

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Phase 2 Completed

Other hematologic neoplasm

Hematologic Neoplasms

NCT01437787 2025-03-05

JAKARTA

Phase 3 Completed

289 enrolled 1 FDA

Other hematologic neoplasm

Hematologic Neoplasms

NCT01523171 2025-03-05

JAKARTA2

Phase 2 Completed

Other hematologic neoplasm

Hematologic Neoplasms